Company intelligence / Profile preview

Fortress Group

Bay Harbor Islands, Florida, United States

Ownership: Private
Development stage: Other

Overview

Fortress Biotech operates a diversified portfolio with eight marketed prescription pharmaceutical products and multiple programs in development. Recent positive results include statistically significant improvement in overall survival for Menkes disease subjects treated with CUTX-101. The company's Checkpoint Therapeutics subsidiary is completing pivotal clinical trial enrollment for cosibelimab (anti-PDL1 antibody). Mustang Bio subsidiary announced in April 2019 that gene therapy for bubble boy disease restored full immune systems in eight treated infants.

Therapeutic areas: OncologyRare DiseasesDermatology
Modalities: Small moleculeGene therapyMonoclonal antibodyAntisense oligonucleotide
Industry: Biotech

Partnerships

AstraZenecaCity of HopeFred Hutchinson Cancer CenterNationwide Children's HospitalSentynlSt. Jude Children's Research HospitalColumbia UniversityNational Institutes of Health

Beyond the preview

Go deeper on Fortress Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fortress Group.

Explore the full profile